WeVote

Bill

Bill

SB 109

Health insurance; requiring coverage of certain genetic testing and cancer imaging; providing exclusions. Effective date.

2026 Regular Session Introduced by Nicole Miller and 1 co-sponsor

Oklahoma requires health insurers to cover designated genetic testing and cancer imaging without patient cost-sharing to improve early disease detection and access.

Becomes law without Governor's signature 05/29/2025
0
WeVote Research Nonpartisan
Bill Summary · SB 109

Legislative bill overview

SB 109 mandates that Oklahoma health insurance plans cover specific genetic testing and cancer imaging procedures without cost-sharing requirements. The bill establishes coverage requirements while providing certain exclusions for particular circumstances or populations.

Why is this important

This legislation directly affects healthcare access and affordability for Oklahomans by removing financial barriers to preventive genetic screening and cancer detection. Early detection of genetic predispositions and cancer imaging can significantly improve treatment outcomes and reduce long-term healthcare costs, though it may increase insurance premiums.

Potential points of contention

  • Cost implications: Mandated coverage without cost-sharing increases insurance expenses, potentially raising premiums for all policyholders and impacting small business insurance costs
  • Scope definition: The bill's specificity regarding which genetic tests and imaging procedures qualify remains unclear, potentially creating disputes between insurers and patients about coverage eligibility
  • Coverage exclusions: The undefined "certain exclusions" language could create inconsistencies in implementation and leave gaps in coverage for some patient populations or circumstances

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.